BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 15711002)

  • 1. Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?
    Lagergren J
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i1-5. PubMed ID: 15711002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of esophageal adenocarcinoma.
    Pera M; Manterola C; Vidal O; Grande L
    J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis?
    Lagergren J
    Best Pract Res Clin Gastroenterol; 2006; 20(5):803-12. PubMed ID: 16997162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori might halt the progress to oesophageal adenocarcinoma in patients with gastro-oesophageal reflux disease and Barrett's oesophagus.
    Kountouras J; Chatzopoulos D; Zavos C
    Med Hypotheses; 2007; 68(5):1174-5. PubMed ID: 17196756
    [No Abstract]   [Full Text] [Related]  

  • 6. Barrett's esophagus and medications that relax the lower esophageal sphincter.
    Corley DA; Levin TR; Habel LA; Buffler PA
    Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study].
    Lagergren J
    Lakartidningen; 2000 Apr; 97(16):1950-3. PubMed ID: 10826353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
    Vial M; Grande L; Pera M
    Recent Results Cancer Res; 2010; 182():1-17. PubMed ID: 20676867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: gastro-oesophageal reflux disease -- how wide is its span?
    Talley NJ
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():27-37; discussion 38-9. PubMed ID: 15456461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in esophageal adenocarcinoma.
    Lagergren J; Lagergren P
    CA Cancer J Clin; 2013; 63(4):232-48. PubMed ID: 23818335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
    Wild CP; Hardie LJ
    Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case-control study.
    Suleiman UL; Harrison M; Britton A; McPherson K; Bates T
    Eur J Cancer Prev; 2000 Jun; 9(3):185-91. PubMed ID: 10954258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oesophageal adenocarcinoma: the new epidemic in men?
    Rutegård M; Lagergren P; Nordenstedt H; Lagergren J
    Maturitas; 2011 Jul; 69(3):244-8. PubMed ID: 21602001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: oesophago-gastric adenocarcinoma -- an epidemiological perspective.
    Forman D
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():55-60; discussion 61-2. PubMed ID: 15456465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk factors for oesophageal adenocarcinoma.
    Lepage C; Drouillard A; Jouve JL; Faivre J
    Dig Liver Dis; 2013 Aug; 45(8):625-9. PubMed ID: 23453359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection and the risk of adenocarcinoma of the esophagus.
    Celiński K; Słomka M; Kasztelan-Szczerbińska B; Madro A; Cichoz-Lach H; Kurzeja A
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):424-7. PubMed ID: 16146024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastro-oesophageal reflux and Helicobacter pylori.
    Pace F; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S289-93. PubMed ID: 10077757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.